Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Y019157 | IM / LA |
Patient reported to pharmacy on 04/28/2025, and stated that she has redness, swelling, felt feverish for several days after the injection on the 16th of April. Patient self treated and stated things settled down over the course of 5 to 7 days, never obtained medical or pharmacy assessment during time of reaction.
Diabetes type 2
Diabetes, hypertension, cardiovascular disease, asthma
ARB, Mounjaro, beta blockers, inhaled steroids, topamax, prozac, dueloxetine, albuterol
Metformin
NONE